Recent study reports that another therapeutic mechanism to prevent ovarian failure is to inhibit granulosa cells apoptosis, human placenta-derived mesenchymal stem cells (hPMSCs) can inhibit granulosa cells apoptosis by modulating stress levels controlled by the IRE1-a pathway [29]. The gene discussed is ERN1; the disease is ovarian dysfunction.